Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Chibale

Showing results (151-160 of 315) with videos related to

Pageof 32
Sort By:
European Journal of Medicinal Chemistry|October 16, 2012
The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivativesMatshawandile Tukulula, Susan Little, Jiri Gut, et al.
ACS Infectious Diseases|February 21, 2023
Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in <i>Plasmodium falciparum</i>, and Synergize with Clinical AntimalarialsJohn Okombo, Malkeet Kumar, Devasha Redhi, et al.
Journal of Medicinal Chemistry|May 26, 2009
Synthesis of novel 2-alkoxy-3-amino-3-arylpropan-1-ols and 5-alkoxy-4-aryl-1,3-oxazinanes with antimalarial activityMatthias D'hooghe, Stijn Dekeukeleire, Karen Mollet, et al.
The FEBS Journal|January 7, 2025
Molecular basis of human angiotensin-1 converting enzyme inhibition by a series of diprolyl-derived compoundsKyle S Gregory, Gyles E Cozier, Stephen Fienberg, et al.
Bioorganic & Medicinal Chemistry|August 19, 2007
Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparumMargaret A L Blackie, Paul Beagley, Simon L Croft, et al.
Journal of Medicinal Chemistry|January 22, 2026
Call for Papers: Medicinal Chemistry and Pharmacology of Antiviral DrugsPeng Zhan, Stefano Alcaro, Scott Pegan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 5, 2025
CYP1A2 contributes to the metabolism of mefloquine: Exploration using in vitro metabolism and physiologically-based pharmacokinetic modellingCleavon K Cloete, Preshendren Govender, Nicholas Njuguna, et al.
European Journal of Medicinal Chemistry|December 25, 2010
Synthesis of 2-(aminomethyl)aziridines and their microwave-assisted ring opening to 1,2,3-triaminopropanes as novel antimalarial pharmacophoresMatthias D'hooghe, Sara Kenis, Karel Vervisch, et al.
European Journal of Medicinal Chemistry|October 21, 2018
Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazolesLaa-Iqa Rylands, Athi Welsh, Keletso Maepa, et al.
European Journal of Medicinal Chemistry|December 9, 2014
Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2Rajni Kant Sharma, Yassir Younis, Grace Mugumbate, et al.
Pageof 32

Showing results (151-160 of 315) with videos related to

Sort By:
Pageof 32
European Journal of Medicinal Chemistry|October 16, 2012
The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivativesMatshawandile Tukulula, Susan Little, Jiri Gut, et al.
ACS Infectious Diseases|February 21, 2023
Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in <i>Plasmodium falciparum</i>, and Synergize with Clinical AntimalarialsJohn Okombo, Malkeet Kumar, Devasha Redhi, et al.
Journal of Medicinal Chemistry|May 26, 2009
Synthesis of novel 2-alkoxy-3-amino-3-arylpropan-1-ols and 5-alkoxy-4-aryl-1,3-oxazinanes with antimalarial activityMatthias D'hooghe, Stijn Dekeukeleire, Karen Mollet, et al.
The FEBS Journal|January 7, 2025
Molecular basis of human angiotensin-1 converting enzyme inhibition by a series of diprolyl-derived compoundsKyle S Gregory, Gyles E Cozier, Stephen Fienberg, et al.
Bioorganic & Medicinal Chemistry|August 19, 2007
Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparumMargaret A L Blackie, Paul Beagley, Simon L Croft, et al.
Journal of Medicinal Chemistry|January 22, 2026
Call for Papers: Medicinal Chemistry and Pharmacology of Antiviral DrugsPeng Zhan, Stefano Alcaro, Scott Pegan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 5, 2025
CYP1A2 contributes to the metabolism of mefloquine: Exploration using in vitro metabolism and physiologically-based pharmacokinetic modellingCleavon K Cloete, Preshendren Govender, Nicholas Njuguna, et al.
European Journal of Medicinal Chemistry|December 25, 2010
Synthesis of 2-(aminomethyl)aziridines and their microwave-assisted ring opening to 1,2,3-triaminopropanes as novel antimalarial pharmacophoresMatthias D'hooghe, Sara Kenis, Karel Vervisch, et al.
European Journal of Medicinal Chemistry|October 21, 2018
Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazolesLaa-Iqa Rylands, Athi Welsh, Keletso Maepa, et al.
European Journal of Medicinal Chemistry|December 9, 2014
Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2Rajni Kant Sharma, Yassir Younis, Grace Mugumbate, et al.
Pageof 32